title: Angiopoietin-like 4 as an Emerging Therapeutic Target for Diabetic Eye Disease.
authors.affiliation: Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
authors.forename: Akrit
authors.initials: A
authors.lastname: Sodhi
authors.affiliation: Department of Oncology and Diagnostic Sciences, School of Dentistry, Greenebaum Cancer Center, University of Maryland, Baltimore3Department of Pathology, School of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore.
authors.forename: Silvia
authors.initials: S
authors.lastname: Montaner
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000075803:Angiopoietin-Like Protein 4; D042682:Angiopoietins / Q000037:antagonists & inhibitors* / Q000502:physiology; D057134:Antibodies, Neutralizing / Q000627:therapeutic use; D001082:Aqueous Humor / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D001813:Blood-Retinal Barrier / Q000502:physiology; D002199:Capillary Permeability / Q000502:physiology; D003930:Diabetic Retinopathy / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D006801:Humans; D008269:Macular Edema / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: C474772:ANGPTL4 protein, human; D020533:Angiogenesis Inhibitors; D000075803:Angiopoietin-Like Protein 4; D042682:Angiopoietins; D057134:Antibodies, Neutralizing; D015415:Biomarkers; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A